MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Deep Brain Stimulation for Early-Onset Parkinson’s Disease: A Systematic Review and Meta-Analysis

    K. Acurio-Ortiz, M. Hemeryth-Rengifo, G. Quispe-Villegas, F. Váscones-Román, V. Abuid-Sampelayo, D. Salazar-Flores, C. Quispe-Vicuña, A. Flores-Gavino, B. Avila-Lucas, M. Vilca-Salas, N. Pacheco-Barrios (Lima, Peru)

    Objective: To evaluate clinical outcomes in patients with Early-Onset Parkinson’s Disease (EOPD) treated with deep brain stimulation (DBS) Background: EOPD is defined as Parkinson’s disease…
  • 2025 International Congress

    Effectiveness and Outcomes of Deep Brain Stimulation revision surgery for Parkinson’s Disease

    MG. Choi, SY. Jo, JH. Lee, SJ. Chung (Goyang-si, Republic of Korea)

    Objective: This study investigated the clinical characteristics, therapeutic efficacy and postoperative outcomes of Parkinson’s disease (PD) patients undergoing deep brain stimulation (DBS) revision surgery Background:…
  • 2025 International Congress

    Association between corneal sensitivity with vision-related quality of life and ocular surface symptoms in Parkinson’s disease

    A. Camacho-Ordonez, M. Navarrete-Azuara, GR. Vera-Duarte, M. Rodriguez-Violante, A. Cervantes-Arriaga, AG. Alcocer-Salas, A. Ramirez-Miranda, EO. Graue-Hernandez (Mexico, Mexico)

    Objective: To evaluate the association between corneal sensitivity (CS) as measured by a non-contact Brill Engines esthesiometer, vision-related quality of life and ocular surface symptoms…
  • 2025 International Congress

    The effect of continuous subcutaneous foslevodopa/foscarbidopa infusion on sleep in Parkinson’s disease: three case reports

    H. Sakuramoto, H. Fujita, K. Suzuki (Shimotuga Mibu, Japan)

    Objective: To assess the effect of continuous subcutaneous infusion of foslevodopa/foscarbidopa (LDP/CDP) on sleep in a patient with Parkinson’s disease (PD). Background: Continuous subcutaneous infusion…
  • 2025 International Congress

    Relating Movement Behaviour and Non-motor Characteristics in People with Parkinson’s Disease: a Compositional Data Analysis Approach

    K. Larsson, H. Johansson, D. Peterson, J. Sedhed, B. Leavy (Stockholm, Sweden)

    Objective: To investigate relationships between relative time spent in different movement intensities (Moderate-vigorous (MVPA)/ light intensity (LIPA) and Sedentary behaviour (SB)) and non-motor characteristics among…
  • 2025 International Congress

    Motor & Non-Motor Symptoms in nOH & RBD

    M. Meyers, G. Smith, K. Bigos, J. Leoutsakos (Baltimore, USA)

    Objective: To assess whether the co-occurrence of neurogenic orthostatic hypotension (nOH) and REM sleep behavior disorder (RBD) is associated with a more severe clinical presentation…
  • 2025 International Congress

    Modifiers of Parkinson’s disease associated with mutations in the GBA1 gene based on transcriptome data validation

    A. Bezrukova, K. Basharova, I. Miliukhina, S. Pchelina, T. Usenko (Gatchina, Russian Federation)

    Objective: To identify modifiers of Parkinson's disease (PD) among carriers of mutations in the GBA1 gene based on transcriptome data validation analysis by the assessing…
  • 2025 International Congress

    Integration of Multivariate Time Series Analysis in Assessing Balance Control: A Comprehensive Review of Current Research

    M. Ali, D. W. Ismail, H. Elshazly, Y. M.HUSSEINY, S. Elrobeigi, Y. Hamdi, M. Abouelseoud, H. Abdelbar, H. Khabiry, M. M. Elsayed (Giza, Egypt)

    Objective: To review the application of multivariate time series (MTS) analysis in assessing balance control and its potential for improving rehabilitation strategies. Background: Balance control…
  • 2025 International Congress

    Using Chronic DBS Brain Sensing Data to Develop an AI-based Engine for Clinical Insights

    E. Fehrmann, A. Nourmohammadi, R. Molina, C. Zarns, M. Case, A. Becker, R. Raike (Minneapolis, USA)

    Objective: Our aim is to build an AI-based algorithm engine to deliver brain sensing-based data insights from deep brain stimulation (DBS) therapy systems that are…
  • 2025 International Congress

    Bridging the Digital Gap: A Global Survey of Technology Adoption by the MDS Technology Study Group

    S. Hirczy, H. Sarva, S. Paul, A. Lane, C. Antoniades, W. Maetzler, A. Mirelman, R. Schneider, J. Hausdorff, J. Vizcarra, J. Klucken, M. Monje, M. Mancini, P. Bonato, A. Nieuwboer, F. Horak, L. Rochester, A. Sanchez-Ferro, M. Fabbri, T. Mestre, R. Reilmann, A. Espay, B. Bloem, R. Bhidayasiri, A. Pilotto (Dallas, USA)

    Objective: To enhance our understanding of the clinical use of digital diagnostic and monitoring technologies among movement disorders clinicians worldwide. Background: The field of movement…
  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley